gg. The conspiracy idea was a joke ...ala BioBill and Marzan's posts .
The MITIGATE data .
U ask me to show 1 yr separation in event lines in a similar population in JELIS .
I've done that .
Now U say patients aren't monitored for statin use etc .
Their medical records , prescription renewals , lipid panels are all monitored within Kaiser.
If patients don't renew their statin scripts patients get contacted by Kaiser. I know ..I'm a Kaiser patient .
They start sending U texts when they estimate your statin supply is running low ( assuming U are taking as directed ).
If you don't renew your script they start emailing you and then start calling you .
Kaiser , in my experience , are very proactive in trying to keep their patients on their meds.
Same with the annual physical . Kaiser is very proactive IMHO in getting their MITIGATE profile patients in for an annual exam. And when you're there they insist on a blood draw if you are ASCVD etc . At least thats my experience .
Its doesn't have to be a fasting blood draw ...they just want a quick look at your LDL levels etc .
I just went thru this . Annual physical last week ...Doc insisted on a quick blood draw while I was there .
What is great about the CAD part of MITIGATE ...is thats its broad ...no LDL levels or TG's specified . Simply ASCVD ...prior event , PCI etc .
The major limitation I can think of is that those in MITIGATE Vascepa arm know they are taking the drug ....and if being part of a clinical trial then encourages more risk reduction behavior ( eg exercising etc ).
In the passive arm ...they don't know they're being followed.
I think this trial is a big deal .
If Kaiser doesn't see any clinically meaningful separation in event lines...especially by the end of this trial ... I suspect they will rethink providing coverage for V
And Dr Nissen will have a field day
Kiwi
News 
Market Data 
Discover 
AI
